🟢 Nanobiotix is trading 5% up in pre-market alongside biotech ETF gains

Nanobiotix is trading 5.29% higher at $25.42 in pre-market on October 21, with biotech-sector strength the likeliest context for the move.

• XBI gained 3.64% in pre-market; no clear company-specific catalyst was identified.
• Nanobiotix rose 14.52% to $24.14 at the October 20 close.
• Its latest disclosure was a routine share-capital and voting-rights update, not a material business announcement. Pre-market volume data was not reported, leaving immediate trading activity unclear.